Young Alethia — SEC insider filings
SEC reporting owner CIK 1918147. 19 insider filings on record with FilingPulse; latest filed 2026-11-17.
Transaction summary — filings shown
Covers all 19 filings on record, filed 2022-04-05 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 5 filings — 20,190 shares, $522,735 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 35.
- Largest priced transaction: sale of 7,000 shares @ $39.90 ($279,300) in PTC THERAPEUTICS, INC., filed 2023-09-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PTC THERAPEUTICS, INC. (PTCT) | Director | 6 | — | 2 legs · 11,666 sh · $464,972 | 16 |
| BICYCLE THERAPEUTICS PLC (BCYC) | Chief Financial Officer | 6 | — | 7 legs · 8,524 sh · $57,762 | 5 |
| Pacira BioSciences, Inc. (PCRX) | Director | 5 | — | — | 12 |
| Graphite Bio, Inc. (GRPH) | Chief Financial Officer | 2 | — | — | 2 |
Insider filings — Young Alethia
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-17 | 4 | Pacira BioSciences, Inc. (PCRX) | Disposition to issuer (D): 17,798 @ $36.50 · Disposition to issuer (D): 12,179 (derivative) · Disposition to issuer (D): 11,279 (derivative) · Disposition to issuer (D): 10,891 (derivative) · Disposition to issuer (D): 30,967 (derivative) | EDGAR |
| 2026-06-12 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 6,405 @ $0 · Grant/award (A): 10,891 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Grant/award (A): 4,000 @ $0 · Grant/award (A): 3,475 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | BICYCLE THERAPEUTICS PLC (BCYC) | Grant/award (A): 50,000 @ $0 · Sale (S): 3,289 @ $6.80 · Sale (S): 2,456 @ $6.45 · Sale (S): 1,878 @ $6.54 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-10-06 | 4 | BICYCLE THERAPEUTICS PLC (BCYC) | Sale (S): 217 @ $8.40 · Sale (S): 265 @ $8.61 | EDGAR |
| 2025-07-07 | 4 | BICYCLE THERAPEUTICS PLC (BCYC) | Sale (S): 204 @ $7.09 | EDGAR |
| 2025-06-13 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 6,163 @ $0 · Grant/award (A): 11,279 (derivative) @ $0 | EDGAR |
| 2025-04-04 | 4 | BICYCLE THERAPEUTICS PLC (BCYC) | Sale (S): 215 @ $8.02 | EDGAR |
| 2025-01-07 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Grant/award (A): 4,000 @ $0 · Grant/award (A): 8,800 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 5,230 @ $0 · Grant/award (A): 12,179 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Grant/award (A): 4,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-01-04 | 4 | BICYCLE THERAPEUTICS plc (BCYC) | Grant/award (A): 12,000 @ $0 · Grant/award (A): 24,000 (derivative) @ $0 | EDGAR |
| 2023-10-11 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 30,967 (derivative) @ $0 | EDGAR |
| 2023-09-08 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Option exercise (M): 7,000 @ $27.85 · Sale (S): 7,000 @ $39.90 · Option exercise (M): 4,666 @ $27.85 · Sale (S): 4,666 @ $39.79 · Option exercise (M): 7,000 (derivative) @ $27.85 · Option exercise (M): 4,666 (derivative) @ $27.85 | EDGAR |
| 2023-07-19 | 4 | BICYCLE THERAPEUTICS plc (BCYC) | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2023-02-23 | 4 | Graphite Bio, Inc. (GRPH) | Grant/award (A): 220,000 (derivative) @ $0 | EDGAR |
| 2023-01-09 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Grant/award (A): 4,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2022-06-10 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Grant/award (A): 3,200 @ $0 · Grant/award (A): 1,867 @ $0 · Grant/award (A): 12,000 (derivative) @ $0 · Grant/award (A): 7,000 (derivative) @ $0 | EDGAR |
| 2022-04-05 | 4 | Graphite Bio, Inc. (GRPH) | Grant/award (A): 350,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1918147 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs